Skip to main content
Livermore
Livermore
ZHEN

Citadel Advisors LLC

SEC CIK
0001423053
Latest filing
Sep 1, 2026

COGT holding history

Cogent Biosciences, Inc. in every 13F filed by Citadel Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

COGT overviewAll 13F holders of COGTFull Q2 2026 holdings

Shares (Q2 2026)
849,694
Value
$32.9M
% of portfolio
<0.1%
Quarters held
20
Since Q1 2021
Holdings of COGT by Citadel Advisors LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026849,694$32.9M<0.1%−865,233−50.5%ReducedHolders
Q1 20261,714,927$66.0M<0.1%+275,933+19.2%AddedHolders
Q4 20251,438,994$51.1M<0.1%−228,813−13.7%ReducedHolders
Q3 20251,667,807$23.9M<0.1%+1,046,572+168.5%AddedHolders
Q2 2025621,235$4.46M<0.1%+131,547+26.9%AddedHolders
Q1 2025489,688$2.93M<0.1%+392,025+401.4%AddedHolders
Q4 202497,663$761.8K<0.1%+88,016+912.4%AddedHolders
Q3 20249,647$104.2K<0.1%+603+6.7%AddedHolders
Q2 20249,044$76.2K<0.1%−122,847−93.1%ReducedHolders
Q1 2024131,891$886.3K<0.1%−508,880−79.4%ReducedHolders
Q4 2023640,771$3.77M<0.1%+580,166+957.3%AddedHolders
Q3 202360,605$590.9K<0.1%−74,162−55.0%ReducedHolders
Q2 2023134,767$1.60M<0.1%−1,161,005−89.6%ReducedHolders
Q1 20231,295,772$14.0M<0.1%−558,548−30.1%ReducedHolders
Q4 20221,854,320$21.4M<0.1%+522,040+39.2%AddedHolders
Q3 20221,332,280$19.9M<0.1%+260,766+24.3%AddedHolders
Q2 20221,071,514$9.66M<0.1%+1,006,013+1,535.9%AddedHolders
Q1 202265,501$491.0K<0.1%+65,501NewHolders
Q4 20210$00.0%−14,340−100.0%Sold outHolders
Q3 202114,340$121.0K<0.1%+14,340NewHolders
Q2 20210$00.0%−1,303,659−100.0%Sold outHolders
Q1 20211,303,659$11.1M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.